PharmaTalkRadio20 Jun 2017

Innovative Ways of Patient Involvement in Medicines Development

Originally recorded at the inaugural Patients as Partners Europe event, held in London in February 2017. Patient, industry, and regulatory perspectives are provided by Alastair Kent of Genetic Alliance UK, Dr Anton Hoos of Amgen Europe, and Isabelle Moulon of the EMD as they discuss on innovative ways of to include patient involvement in medicines development. The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials and developing a clinical endpoint, as well as vastly improve the patient's entire experience in a clinical trial. The 2nd annual Patients as Partners EU event will be held January 23-24, 2018 at Radisson Blu Portman Hotel, London, UK.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges

For more information, visit theconferenceforum.org

9 Des 202438min

CMO Misunderstandings about Clinical Operations and How to Improve

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical ope...

5 Des 202433min

How Roche is Maximizing the Impact of Patient Insights in Early Development

For more information, go to theconferenceforum.org

3 Des 202419min

Designing and Developing Drug Delivery for Lower and Middle-Income Countries

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and Abb...

21 Nov 202442min